top of page


สาธารณะ·สมาชิก 29 คน

Where Do I Buy Marijuana Stocks

Even though the cannabis industry is growing, there are only a few dozen publicly-traded players. And because Canada legalized recreational marijuana in 2017, many pot stocks are headquartered there. In general, cannabis companies are broken down into the following categories:

where do i buy marijuana stocks

Growers: These are the companies that grow and sell the plant, and are most directly linked to products ultimately sold at dispensaries. Examples of such products include: medical marijuana, recreational marijuana, and items that include CBD (cannabidiol).

Because of the inherent risks related to investing in individual stocks, some investors may prefer to invest in exchange-traded funds (ETFs). There are nine ETFs that invest across those three aforementioned categories of companies and are traded on the U.S. stock market:

You may already be investing in marijuana stocks without realizing it, particularly if your portfolio includes any index funds that track small-cap stocks. For example, Scotts Miracle-Gro is included in more than 150 ETFs, while Tilray is a member of nearly 20, according to

Finally, the cannabis industry is evolving, so you must be comfortable with volatile price action in stocks and the possibility of companies going out of business. Some companies in this industry have drawn the interest of day traders on sites like Reddit, which has caused even more volatility. And the SEC warns investors about potential fraud related to microcap stocks more generally, and cannabis stocks specifically.

In addition, other types of cannabis products fall under the umbrella of the marijuana market. Some of the most common medical marijuana products include cannabidiol (CBD) or tetrahydrocannabinol (THC).

Both CBD and THC are naturally occurring compounds, and they are usually used to treat illnesses such as chemotherapy-induced anorexia, nausea, or vomiting. Recreational marijuana, on the other hand, is usually ingested either through smoking the cannabis plant or by consuming cannabis edibles.

When choosing a brokerage to open an account with, consider what features you find most important. For example, some brokerages specialize in simplified mobile/online trading, whereas others offer extensive stock market tools that you can use for analysis. Here are a few popular options to get you started:

The marijuana industry is growing rapidly, as more and more states legalize the drug on both a medicinal and recreational level. Just like any other burgeoning industry, the marijuana market is attracting plenty of investors.

But while 2023 might not be a year to buy in expectation of rapid gains, this could be a great entry point for purchasing some solid cannabis stocks at a discount and holding them in anticipation of eventual federal legalization in the U.S., the world's biggest pot market.

Like many firms in other industries, cannabis companies have been struggling with high inflation adding to their costs. But marijuana companies also face a host of headwinds unique to them, including competition from the illegal market and falling prices for marijuana because of competition and oversupply.

In Canada, despite federal legality, the industry has been weighed down by high taxes. In the U.S., where the drug remains federally illegal, taxes are also high, and the industry faces onerous hurdles to financing from banks. Because of federal illegality in the U.S., plant-touching companies can't list on major exchanges, and many institutional investors don't want to buy shares of companies trading over the counter, limiting marijuana firms' ability to raise money.

"From a stock perspective, the marijuana industry has not experienced the same bounce back that other beaten-down sectors have experienced since the market's bottom in October," said Tom Bruni, senior writer for The Daily Rip & Markets newsletter at Stocktwits. "Part of that is because, from a regulatory or business standpoint, there have yet to be any significant catalysts to spark a renewed interest in the space."

A silver lining for operators in mature markets facing slowing sales growth is that falling marijuana prices because of competition and oversupply should help the legal market compete with the illicit one, according to Jason Wilson, cannabis research and banking expert at ETF Managers Group. While that might not move the needle for share prices in 2023, it should be beneficial in the longer term, he said.

On the StockTwits platform, there are only two pot stocks held by popular exchange-traded fund ETFMG Alternative Harvest ETF (MJ) that have a bullish sentiment reading: SNDL Inc. (SNDL) and Cronos, according to Bruni.

Marijuana stocks have given cannabis investors nothing but false starts over the past few years. Most recently, there were a plethora of issues facing the industry throughout 2022, including inflation, overproduction, lack of capital, job losses and cratering stock prices.

The long-term prognosis for the cannabis industry is good. Ultimately, the following nine picks look like the best marijuana stocks (and funds) to benefit from this ongoing growth and maturation.

On the consumer side of cannabis, it has a $150 million six-year convertible note in RIV Capital (CNPOF (opens in new tab)), which represents a 42% stake. In March 2022, RIV Capital acquired Etain Health (opens in new tab), one of New York state's original medical marijuana producers, for $247 million. Etain has one of 10 vertically integrated licenses from the state.

Still, IIPR remains one the best REITs on Wall Street, as well as one of the best marijuana stocks, according to analysts. Piper Sandler analyst Alexander Goldfarb has an Overweight rating (the equivalent of Buy) on IIPR, with a $140 target price, some 55% higher than current levels.

If you're looking for a pure-play cannabis company in the U.S., Massachusetts-based Curaleaf Holdings (CURLF (opens in new tab), $3.82) is one way to go. The firm got its start in New Jersey in 2010, developing one of the first vaporizers to administer a single measured medical marijuana dose.

A total of 39 states, as well as Washington, D.C., have legalized medical marijuana. Twenty-one states and D.C. have legalized adult-use cannabis. As more states legalize recreational weed, Curaleaf should be able to continue to grow its business organically and through acquisitions.

Cresco is one of Wall Street's favorite marijuana stocks. Of the 19 analysts following the stock, 13 give it a Strong Buy, three say it's a Buy, and three have it at Hold. Plus, the average target price of $6.88 implies the stock will more than triple over the next 12 months or so.

Not forgetting that this is an article about the best marijuana stocks, British American Tobacco invested an additional $5.1 million last March in Canadian cannabis producer OrganiGram Holdings (OGI (opens in new tab)), bringing its stake in the company to 19.5%. The two continue to collaborate on new cannabis-related products.

Kiplinger contributor Matt Hawkins discussed the pros and cons of investing in multi-state operators in September 2021. The biggest positive, in his view, is the fact they're building brand loyalty in the states where they operate while biding their time when they can go nationwide.

By comparison, the MJ ETF follows the performance of the Prime Alternative Harvest Index, which in addition to tracking cannabis stocks, also includes cigarette manufacturers such as Altria (MO (opens in new tab)) and a 20.1% weighting in the ETFMG U.S. Alternative Harvest ETF (MJUS (opens in new tab)). As a result of the ETF weighting, the Canadian content in MJ is slightly less than 42%.

Cannabis stocks jumped in early October, after President Joe Biden took the United States closer to federal marijuana legalization. But these stocks have since lost ground as Biden's pronouncement does little in the short term to change the industry.

Biden said he would pardon people convicted of the federal crime of simple marijuana possession, called on governors to make similar moves for convictions under state laws and ordered a review of the way marijuana is federally scheduled as a controlled substance. But that is a far cry from full legalization that would lead to a sustained rally in marijuana stocks.

Like many other companies, cannabis stocks have been under pressure because of inflation, higher interest rates and the general negative market sentiment as investors worry about a potential recession.

But these companies were already in a downtrend before the broader market took a turn for the worse. Cannabis stocks were underperforming after Democratic political gains in 2020 and 2021 failed to produce meaningful legislative reform, leaving companies to face a host of issues traditional businesses don't.

Cannabis companies headquartered in the United States, or anywhere that marijuana isn't legal, can't raise money in the stock market by listing on the New York Stock Exchange or Nasdaq if they grow, process or sell marijuana, a Schedule I drug alongside heroin and LSD. (Many publicly traded cannabis companies are headquartered in Canada, where the drug is federally legal, or trade over-the-counter.)

Biden's announcement in early October doesn't change any of this immediately. But it may eventually help unlock reform from Congress, where a cannabis banking bill has been stalled by those who want wider-reaching legalization and social justice changes.

Still, there are plenty of positives for the U.S. marijuana industry, which has already taken great strides even while operating under federal prohibition. That means these marijuana stocks are primed to move significantly higher if meaningful federal reform does end up taking place.

"I anticipate that most cannabis stocks will skyrocket once we truly legalize cannabis on the federal level," says Andrew Bowden, CEO of dispensary franchisor Item 9 Labs Corp. (ticker: INLB). Until that happens "we will continue seeing these small wins along the way that will positively impact cannabis stocks," he says. 041b061a72


ยินดีต้อนรับเข้ากลุ่ม! แชร์ความรู้เกี่ยวกับทำผม เทคนิคต่างๆ ...


  • Mike Jason
    Mike Jason
  • Jack Warner
    Jack Warner
  • Justin Hert
    Justin Hert
  • Nikk
bottom of page